Pfizer Loses in Court ... Again - Ed Silverman writes

The Nevada Supreme Court has upheld a $58 million judgment that was awarded to three Nevada women, who claimed they suffered breast cancer after taking the Prempro hormone replacement therapy made by Wyeth, which is now owned by Pfizer (PFE). The ruling confirms a 2007 decision in favor of Arlene Rowatt, Jeraldine Scofield and Pamela Forrester, who were originally awarded $134 million, but that was later reduced by the trial judge (back story here and here). Forrester and Rowatt, however, have reportedly since passed away.

In explaining the 6-0 decision, Justice Michael Cherry wrote noted that studies dating back to the 1980s found links between breast cancer and the drug. Yet, he wrote, “internal Wyeth documents show that it responded to studies suggesting a possible breast cancer risk by downplaying the risk through public relations campaigns and its sales representatives’ interactions with physicians” (read the ruling here).

via seekingalpha.com

Posted via email from Jack's posterous